BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 569499)

  • 21. On the activation of bovine chymotrypsinogen A. Conformational isomerization of alpha1- and kappa-chymotrypsin and their autolytic conversion to alpha- and gamma-chymotrypsin.
    Sharma SK; Hopkins TR
    J Biol Chem; 1978 May; 253(9):3055-61. PubMed ID: 565358
    [No Abstract]   [Full Text] [Related]  

  • 22. The reaction of an alpha-aza-amino acid derivative with chymotrypsin and its use as a ligand for covalent affinity purification.
    Barker SA; Gray CJ; Ireson JC; Parker RC; McLaren JV
    Biochem J; 1974 Jun; 139(3):555-63. PubMed ID: 4605321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catalysis by chymotrypsinogen. Demonstration of an acyl-zymogen intermediate.
    Gertler A; Walsh KA; Neurath H
    Biochemistry; 1974 Mar; 13(6):1302-10. PubMed ID: 4856029
    [No Abstract]   [Full Text] [Related]  

  • 24. The three-dimensional structure of the native ternary complex of bovine pancreatic procarboxypeptidase A with proproteinase E and chymotrypsinogen C.
    Gomis-Rüth FX; Gómez M; Bode W; Huber R; Avilés FX
    EMBO J; 1995 Sep; 14(18):4387-94. PubMed ID: 7556081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragmentation of bovine chymotrypsinogen A and chymotrypsin A-alpha. Specific cleavage at arginine and methionine residues and separation of peptides, including B and C chains of chymotrypsin.
    Hapner KD; Wilcox PE
    Biochemistry; 1970 Nov; 9(23):4470-80. PubMed ID: 5474142
    [No Abstract]   [Full Text] [Related]  

  • 26. Crystal structure of an oligomer of proteolytic zymogens: detailed conformational analysis of the bovine ternary complex and implications for their activation.
    Gomis-Rüth FX; Gómez-Ortiz M; Vendrell J; Ventura S; Bode W; Huber R; Avilés FX
    J Mol Biol; 1997 Jun; 269(5):861-80. PubMed ID: 9223647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of chronic ethanol ingestion on the pancreatic proteolytic enzymes and their inhibitors in the rat.
    Jalovaara P; Huttunen R
    Scand J Gastroenterol; 1977; 12(7):785-92. PubMed ID: 563615
    [No Abstract]   [Full Text] [Related]  

  • 28. The iodination of chymotrypsinogen and chymotrypsin in crystal and solution. Its effect upon the products of activation and catalytic activity.
    Wright HT; Weber BH
    Eur J Biochem; 1972 Jan; 24(3):583-92. PubMed ID: 5058601
    [No Abstract]   [Full Text] [Related]  

  • 29. Pancreatic proteolytic enzymes of ostrich purified on immobilized protein inhibitors. Characterization of a new form of chymotrypsin (Chtr1).
    Zelazko M; Chrzanowska J; Polanowski A
    Comp Biochem Physiol B Biochem Mol Biol; 2008 Sep; 151(1):102-9. PubMed ID: 18598777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probes of the mechanism of zymogen catalysis.
    Lonsdale-Eccles JD; Neurath H; Walsh KA
    Biochemistry; 1978 Jul; 17(14):2805-9. PubMed ID: 687564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refolding of serine proteinases.
    Light A; Duda CT; Odorzynski TW; Moore WG
    J Cell Biochem; 1986; 31(1):19-26. PubMed ID: 3522609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of hydrogen exchange in proteins. 3. The effects of the chymotrypsinogen-alpha chymotrypsin conversion on hydrogen exchange kinetics.
    Rosenberg A; Woodward CK
    J Biol Chem; 1970 Sep; 245(18):4677-83. PubMed ID: 5456142
    [No Abstract]   [Full Text] [Related]  

  • 33. Reevaluation of the activation of bovine chymotrypsinogen A.
    Miller DD; Horbett TA; Teller DC
    Biochemistry; 1971 Dec; 10(25):4641-8. PubMed ID: 5168678
    [No Abstract]   [Full Text] [Related]  

  • 34. On the structural and functional role of carboxylates in chymotrypsinogen A: a comparison with chymotrypsin, trypsinogen and trypsin.
    Abita JP; Lazdunski M
    Biochem Biophys Res Commun; 1969 Jun; 35(5):707-12. PubMed ID: 5794088
    [No Abstract]   [Full Text] [Related]  

  • 35. New properties of chymotrypsin modified by fixation with a hydrophobic molecule: hexanal.
    Remy MH; Bourdillon C; Thomas D
    Ann N Y Acad Sci; 1984; 434():343-6. PubMed ID: 6596900
    [No Abstract]   [Full Text] [Related]  

  • 36. Is -chymotrypsin an autolytic product in the activation scheme of chymotrypsinogen A?
    Avery MJ; Hopkins TR
    Biochim Biophys Acta; 1973 May; 310(1):142-7. PubMed ID: 4736335
    [No Abstract]   [Full Text] [Related]  

  • 37. Preparation and properties of trypsin and chymotrysin coupled covalently to poly (N-vinylpyrrolidone).
    Specht BU; Brendel W
    Biochim Biophys Acta; 1977 Sep; 484(1):109-14. PubMed ID: 889841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of zymogen activation.
    Stroud RM; Kossiakoff AA; Chambers JL
    Annu Rev Biophys Bioeng; 1977; 6():177-93. PubMed ID: 17350
    [No Abstract]   [Full Text] [Related]  

  • 39. Aspergillus oryzae acid proteinase. Purification and properties, and formation of pi-chymotrypsin.
    Davidson R; Gertler A; Hofmann T
    Biochem J; 1975 Apr; 147(1):45-53. PubMed ID: 239702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of chymotrypsin(ogen) in the thioredoxin reductase deficient mutant strain of Escherichia coli AD494(DE3) and purification via a fusion product with a hexahistidine-tail.
    Verheyden G; Volckaert G; Engelborghs Y
    J Chromatogr B Biomed Sci Appl; 2000 Jan; 737(1-2):213-24. PubMed ID: 10681058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.